Mitch Chargo Unpacks How Rescheduling Cannabis to Schedule III Will Benefit Cannabis Businesses
In The News | 2 min read
Dec 30, 2025
Hinshaw Minneapolis partner Mitch Chargo was featured in several media stories by AZ Big Media and KTTC Rochester discussing the significance of President Donald Trump’s Executive Order that reschedules cannabis from a Schedule I to a Schedule III substance.
Tax Benefits
Although the Executive Order does not legalize cannabis nationwide, Mitch highlights how this change could greatly benefit cannabis businesses in states where the drug is legal, such as Minnesota and Arizona.
One of those benefits can be tax relief and access to federal banking for business owners. “There is a provision known as 280E, which is really a punitive tax statute that negatively impacts cannabis operators, not only in Minnesota, but around the country,” he said.
Additionally, Mitch notes that these tax code changes alone could improve operators’ cash flow, stabilize pricing, and strengthen the long-term viability of the industry.
Ongoing Challenges Following the Reschedule
Mitch also discusses some of the ongoing challenges presented by the Schedule I classification, including the banking hurdles faced by cannabis operators.
“The Schedule I nature of the substance makes it almost impossible for cannabis operators to have access to normal banking, at least federally insured and federally chartered banks,” he said.
Even with rescheduling, Mitch points to unresolved tensions between Food and Drug Administration oversight of Schedule III medical drugs and the realities of adult recreational use products. The persistent gap between federal law and state-regulated markets—such as in Arizona—continues to cause confusion among patients, businesses, and regulators. He emphasizes that while rescheduling is a meaningful step, it does not eliminate the need for clarity between federal and state policy.
Timeline and Outlook
Lastly, Mitch notes that the rescheduling process will likely not be finalized until later in 2026, but it marks a significant step forward for the cannabis market. “We’re not at the finish line, and there are still many steps to go before this becomes official. But this is a pivotal moment. Thoughtful policy changes like this help bring marijuana out of the shadows and into a space where education, research, responsible regulation, and opportunity can continue to grow.”
Media Coverage
-
- AZ Big Media: “What does cannabis rescheduling mean for Arizona?” (December 22, 2025)
- KTTC: “Trump signs executive order to reschedule cannabis from Schedule I to Schedule III” (December 18, 2025)
Related People
Related Capabilities
Related Locations
Featured Insights

Event
Apr 23, 2026
Driving Ahead: Insights from Industry Leaders Auto Finance Seminar

Healthcare Alert
Mar 26, 2026
Are You Beyond the Red Line? Mastering Your FQHC’s Scope of Project to Avoid Noncompliance

Webinar
Mar 24, 2026
David Alfini on How Regulatory Citations Become Senior Living Risk

Consumer Crossroads: Where Financial Services and Litigation Intersect
Mar 18, 2026
How Should Entities Prepare for California’s New DFAL Licensing Requirement?

Webinar
Mar 17, 2026
Legal Insights on Medical Aid in Dying from Katie Anderson and Adam Guetzow

Consumer Crossroads: Where Financial Services and Litigation Intersect
Mar 13, 2026
DOJ Settlement with Car Retailer Highlights SCRA Repossession Risks

Privacy, Cyber & AI Decoded Alert
Mar 11, 2026
Compliance Considerations for GDPR Consent in Biotech Clinical Research





![[VIDEO] Lucy Wang Featured in Business Interview TV Series](/a/web/28aUdvEJH2Txwy8MGsu35J/bo3TFX/featured-in-the-business-insurance-business-interview-series-insights.jpg)
